Search research articles
Contact Us
Filters
Showing results (291-300 of 768) with videos related to
Page
of 77
Sort By:
American Journal of Surgery
|
July 24, 2002
Glypican-3 expression is markedly decreased in human gastric cancer but not in esophageal cancer
Zhaowen Zhu, Helmut Friess, Jörg Kleeff, et al.
The American Journal of Pathology
|
September 30, 2005
Secretin receptors in normal and diseased human pancreas: marked reduction of receptor binding in ductal neoplasia
Meike Körner, Gregory M Hayes, Ruth Rehmann, et al.
Deutsches Arzteblatt International
|
June 11, 2021
Acute Appendicitis: Trends in Surgical Treatment—A Population-Based Study of Over 800 000 Patients
Christian Stöß, Ulrich Nitsche, Philipp-Alexander Neumann, et al.
BMC Surgery
|
December 4, 2020
The COVID-19 pandemic: impact on surgical departments of non-university hospitals
Christian Stöß, Marcella Steffani, Kay Kohlhaw, et al.
Annals of Surgical Oncology
|
March 21, 2008
Most pancreatic cancer resections are R1 resections
Irene Esposito, Jörg Kleeff, Frank Bergmann, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
July 5, 2005
Expression analysis of PMP22/Gas3 in premalignant and malignant pancreatic lesions
Junsheng Li, Jörg Kleeff, Irene Esposito, et al.
Neoplasia (New York, N.Y.)
|
February 28, 2007
Tumor-suppressor function of SPARC-like protein 1/Hevin in pancreatic cancer
Irene Esposito, Hany Kayed, Shereen Keleg, et al.
Biomedicines
|
March 28, 2024
Cell Death in Liver Disease and Liver Surgery
Christian Stoess, Yeon-Kyung Choi, Janset Onyuru, et al.
Surgery
|
January 8, 2022
Drain use in pancreatic surgery: Results from an international survey among experts in the field
Ilaria Pergolini, Stephan Schorn, Rüdiger Goess, et al.
Cancer
|
July 28, 2011
Prolyl hydroxylase-2 (PHD2) exerts tumor-suppressive activity in pancreatic cancer
Yun Su, Martin Loos, Natalia Giese, et al.
Page
of 77
Search research articles
Search
Showing results (291-300 of 768) with videos related to
Sort By:
Page
of 77
American Journal of Surgery
|
July 24, 2002
Glypican-3 expression is markedly decreased in human gastric cancer but not in esophageal cancer
Zhaowen Zhu, Helmut Friess, Jörg Kleeff, et al.
The American Journal of Pathology
|
September 30, 2005
Secretin receptors in normal and diseased human pancreas: marked reduction of receptor binding in ductal neoplasia
Meike Körner, Gregory M Hayes, Ruth Rehmann, et al.
Deutsches Arzteblatt International
|
June 11, 2021
Acute Appendicitis: Trends in Surgical Treatment—A Population-Based Study of Over 800 000 Patients
Christian Stöß, Ulrich Nitsche, Philipp-Alexander Neumann, et al.
BMC Surgery
|
December 4, 2020
The COVID-19 pandemic: impact on surgical departments of non-university hospitals
Christian Stöß, Marcella Steffani, Kay Kohlhaw, et al.
Annals of Surgical Oncology
|
March 21, 2008
Most pancreatic cancer resections are R1 resections
Irene Esposito, Jörg Kleeff, Frank Bergmann, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
July 5, 2005
Expression analysis of PMP22/Gas3 in premalignant and malignant pancreatic lesions
Junsheng Li, Jörg Kleeff, Irene Esposito, et al.
Neoplasia (New York, N.Y.)
|
February 28, 2007
Tumor-suppressor function of SPARC-like protein 1/Hevin in pancreatic cancer
Irene Esposito, Hany Kayed, Shereen Keleg, et al.
Biomedicines
|
March 28, 2024
Cell Death in Liver Disease and Liver Surgery
Christian Stoess, Yeon-Kyung Choi, Janset Onyuru, et al.
Surgery
|
January 8, 2022
Drain use in pancreatic surgery: Results from an international survey among experts in the field
Ilaria Pergolini, Stephan Schorn, Rüdiger Goess, et al.
Cancer
|
July 28, 2011
Prolyl hydroxylase-2 (PHD2) exerts tumor-suppressive activity in pancreatic cancer
Yun Su, Martin Loos, Natalia Giese, et al.
Page
of 77